Clindamycin hydrochloride labels and packages
Clindamycin hydrochloride |
---|
CLEOCIN HYDROCHLORIDE® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
How Supplied |
Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label
NDC 0009-0331-02
100 Capsules Rx only
Cleocin HCl® clindamycin hydrochloride capsules, USP
75 mg*
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Bottle Label
NDC 0009-0225-02
100 Capsules Rx only
Cleocin HCl® clindamycin hydrochloride capsules, USP
150 mg*
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Blister Pack
Cleocin HCl® clindamycin hydrochloride capsules, USP 150 mg
Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc NY, NY 10017
EXP 00/0000 LOT 00XXX
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Blister Pack Carton
NDC 0009-0225-03
100 Capsules Rx only
Cleocin HCl® clindamycin hydrochloride capsules, USP
150 mg*
For in-institution use only
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
PRINCIPAL DISPLAY PANEL - 300 mg Capsule Bottle Label
NDC 0009-0395-14
100 Capsules Rx only
Cleocin HCl® clindamycin hydrochloride capsules, USP
300 mg*
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
PRINCIPAL DISPLAY PANEL - 300 mg Capsule Blister Pack
Cleocin HCl® clindamycin hydrochloride capsules, USP
300 mg
Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
EXP 00/0000 LOT 00XXX
PRINCIPAL DISPLAY PANEL - 300 mg Capsule Blister Pack Carton
NDC 0009-0395-02
100 Capsules Rx only
Cleocin HCl® clindamycin hydrochloride capsules, USP
300 mg*
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf